• Newsletter
  • Search
  • Contacto
  • Home (next newsletter)
  • Home
  • News # 80 | Jun. 2018
  • News # 81 | Jul. 2018
  • News # 82 | Set. 2018
  • News # 83 | Oct. 2018
  • News # 84 | Nov. 2018
  • News # 85 | Dec. 2018
  • News # 86 | Jan. 2019
  • News # 87 | Feb. 2019
  • News # 88 | Mar. 2019
  • News # 89 | Apr. 2019
  • News # 90 | May. 2019
  • News # 91 | Jun. 2019
  • News # 92 | Jul. 2019
  • News # 93 | sep. 2019
  • Newsletters
    • 2008 – 2009
      • News # 1 | nov. 2008
      • News # 10 | nov/dez. 2009
      • News # 2 | dec. 2008
      • News # 3 | jan/fev. 2009
      • News # 4 | mar. 2009
      • News # 5 | abr. 2009
      • News # 6 | mai/jun. 2009
      • News # 7 | jul. 2009
      • News # 8 | ago/set. 2009
      • News # 9 | out. 2009
    • 2010 – 2011
      • News # 11 | jan/fev. 2010
      • News # 12 | mar. 2010
      • News # 13 | abr. 2010
      • News # 14 | mai. 2010
      • News # 15 | jun/jul. 2010
      • News # 16 | ago/set. 2010
      • News # 17 | out/nov. 2010
      • News # 18 | dez. 2010
      • News # 19 | jan/fev. 2011
      • News # 20 | mar/abr. 2011
      • News # 21 | mai/jun. 2011
      • News # 22 | jul/ago. 2011
      • News # 23 | set/out. 2011
      • News # 24 | nov/dez. 2011
    • 2012 – 2013
      • News # 25 | jan. 2012
      • News # 26 | fev/mar. 2012
      • News # 27 | jun. 2012
      • News # 28 | ago. 2012
      • News # 29 | set/out. 2012
      • News # 30 | nov/dez. 2012
      • News # 31 | jan. 2013
      • News # 32 | mar. 2013
      • News # 33 | abr. 2013
      • News # 34 | mai. 2013
      • News # 35 | jun. 2013
      • News # 36 | set. 2013
      •  News # 37 | out. 2013
      • News # 38 | nov/dez. 2013
    • 2014 – 2015
      • News # 39 | jan/fev. 2014
      • News # 40 | mar. 2014
      • News # 41 | abr/mai. 2014
      • News # 42 | jun/jul. 2014
      • News # 43 | set. 2014
      • News # 44 | out/nov. 2014
      • News # 45 | dez. 2014
      • News # 46 | jan. 2015
      • News # 47 | fev. 2015
      • News # 48 | abr. 2015
      • News # 49 | mai. 2015
      • News # 50 | jun. 2015
      • News # 51 | set. 2015
      • News # 52 | out. 2015
      • News # 53 | dez. 2015
    • 2016 – 2017
      • News # 54 | jan. 2016
      • News # 55 | fev. 2016
      • News # 56 | mar. 2016
      • News # 57 | abr. 2016
      • News nº 58 | may 2016
      • News # 59 | jun. 2016
      • News # 60 | jul. 2016
      • News # 61 | set. 2016
      • News # 62 | out. 2016
      • News # 63 | nov/dez. 2016
      • News # 64 | jan. 2017
      • News # 65 | fev. 2017
      • News # 66 | mar. 2017
      • News # 67 | apr. 2017
      • News # 68 | may 2017
      • News # 69 | jun. 2017
      • News # 70 | jul. 2017
      • News # 71 | set. 2017
      • News # 72 | out. 2017
      • News # 73 | nov. 2017
      • News # 74 | dez. 2017
    • 2018
      • News # 75 | jan. 2018
      • News # 76 | fev. 2018
      • News # 77 | mar. 2018
      • News # 78 | abr. 2018
      • News #79 | May 2018
  • Subscribe Newsletter
My Company
  • Home
  • Newsletters
    • 2018 – 2019
      • News nº 92 | jul. 2019
      • News nº 91 | jun. 2019
      • News nº 90 | Mai. 2019
      • News nº 89 | Abr. 2019
      • News nº 88 | Mar. 2019
      • News nº 87 | Fev. 2019
      • News nº 86 | Jan. 2019
      • News nº 85 | Dez. 2018
      • News nº 84 | Nov. 2018
      • News nº 83 | Out. 2018
      • News nº 82 | Set. 2018
      • News nº 81 | Jul. 2018
      • News nº 80 | Jun. 2018
      • News Nº 79 | Mai. 2018
      • News nº 78 | abr. 2018
      • News nº 77 | mar. 2018
      • News nº 76 | fev. 2018
      • News nº 75 | jan. 2018
    • 2016 – 2017
      • News nº 74 | dez. 2017
      • News # 73 | nov. 2017
      • News # 72 | out. 2017
      • News # 70 | set. 2017
      • News nº 70 | jul. 2017
      • News nº 69 | jun. 2017
      • News nº 68 | mai. 2017
      • News nº 67 | abr. 2017
      • News nº 66 | mar. 2017
      • News nº 65 | fev. 2017
      • News nº 64 | jan. 2017
      • News nº 63 | nov/dez. 2016
      • News nº 62 | out. 2016
      • News nº 61 | set. 2016
      • News nº 60 | jul. 2016
      • News nº 59 | jun. 2016
      • News nº 58 | mai. 2016
      • News nº 57 | abr. 2016
      • News nº 56 | mar. 2016
      • News nº 55 | fev. 2016
      • News nº 54 | jan. 2016
    • 2014 – 2015
      • News nº 53 | dez. 2015
      • News nº 52 | out. 2015
      • News nº 51 | set. 2015
      • News nº 50 | jun. 2015
      • News nº 49 | mai. 2015
      • News nº 48 | abr. 2015
      • News nº 47 | fev. 2015
      • News nº 46 | jan. 2015
      • News nº 45 | dez. 2014
      • News nº 44 | out/nov. 2014
      • News nº 43 | set. 2014
      • News nº 42 | jun/jul. 2014
      • News nº 41 | abr/mai. 2014
      • News nº 40 | mar. 2014
      • News nº 39 | jan/fev. 2014
    • 2012 – 2013
      • News nº 38 | nov/dez. 2013
      • News nº 37 | out. 2013
      • News nº 36 | set. 2013
      • News nº 35 | jun. 2013
      • News nº 34 | mai. 2013
      • News nº 33 | abr. 2013
      • News nº 32 | mar. 2013
      • News nº 31 | jan. 2013
      • News nº 30 | nov/dez. 2012
      • News nº 29 | set/out. 2012
      • News nº 28 | ago. 2012
      • News nº 27 | jun. 2012
      • News nº 26 | fev/mar. 2012
      • News nº 25 | jan. 2012
    • 2010 – 2011
      • News nº 24 | nov/dez. 2011
      • News nº 23 | set/out. 2011
      • News nº 22 | jul/ago. 2011
      • News nº 21 | mai/jun. 2011
      • News nº 20 | mar/abr. 2011
      • News nº 19 | jan/fev. 2011
      • News nº 18 | dez. 2010
      • News nº 17 | out/nov. 2010
      • News nº 16 | ago/set. 2010
      • News nº 15 | jun/jul. 2010
      • News nº 14 | mai. 2010
      • News nº 13 | abr. 2010
      • News nº 12 | mar. 2010
      • News nº 11 | jan/fev. 2010
    • 2008 – 2009
      • News nº 10 | nov/dez. 2009
      • News nº 9 | out. 2009
      • News nº 8 | ago/set. 2009
      • News nº 7 | jul. 2009
      • News nº 6 | mai/jun. 2009
      • News nº 5 | abr. 2009
      • News nº 4 | mar. 2009
      • News nº 3 | jan/fev. 2009
      • News nº 2 | dez. 2008
      • News nº 1 | nov. 2008
  • Subscrever Newsletter
  • Contacto
Main Menu
  • Home
  • Newsletters
    • 2018 – 2019
      • News nº 92 | jul. 2019
      • News nº 91 | jun. 2019
      • News nº 90 | Mai. 2019
      • News nº 89 | Abr. 2019
      • News nº 88 | Mar. 2019
      • News nº 87 | Fev. 2019
      • News nº 86 | Jan. 2019
      • News nº 85 | Dez. 2018
      • News nº 84 | Nov. 2018
      • News nº 83 | Out. 2018
      • News nº 82 | Set. 2018
      • News nº 81 | Jul. 2018
      • News nº 80 | Jun. 2018
      • News Nº 79 | Mai. 2018
      • News nº 78 | abr. 2018
      • News nº 77 | mar. 2018
      • News nº 76 | fev. 2018
      • News nº 75 | jan. 2018
    • 2016 – 2017
      • News nº 74 | dez. 2017
      • News # 73 | nov. 2017
      • News # 72 | out. 2017
      • News # 70 | set. 2017
      • News nº 70 | jul. 2017
      • News nº 69 | jun. 2017
      • News nº 68 | mai. 2017
      • News nº 67 | abr. 2017
      • News nº 66 | mar. 2017
      • News nº 65 | fev. 2017
      • News nº 64 | jan. 2017
      • News nº 63 | nov/dez. 2016
      • News nº 62 | out. 2016
      • News nº 61 | set. 2016
      • News nº 60 | jul. 2016
      • News nº 59 | jun. 2016
      • News nº 58 | mai. 2016
      • News nº 57 | abr. 2016
      • News nº 56 | mar. 2016
      • News nº 55 | fev. 2016
      • News nº 54 | jan. 2016
    • 2014 – 2015
      • News nº 53 | dez. 2015
      • News nº 52 | out. 2015
      • News nº 51 | set. 2015
      • News nº 50 | jun. 2015
      • News nº 49 | mai. 2015
      • News nº 48 | abr. 2015
      • News nº 47 | fev. 2015
      • News nº 46 | jan. 2015
      • News nº 45 | dez. 2014
      • News nº 44 | out/nov. 2014
      • News nº 43 | set. 2014
      • News nº 42 | jun/jul. 2014
      • News nº 41 | abr/mai. 2014
      • News nº 40 | mar. 2014
      • News nº 39 | jan/fev. 2014
    • 2012 – 2013
      • News nº 38 | nov/dez. 2013
      • News nº 37 | out. 2013
      • News nº 36 | set. 2013
      • News nº 35 | jun. 2013
      • News nº 34 | mai. 2013
      • News nº 33 | abr. 2013
      • News nº 32 | mar. 2013
      • News nº 31 | jan. 2013
      • News nº 30 | nov/dez. 2012
      • News nº 29 | set/out. 2012
      • News nº 28 | ago. 2012
      • News nº 27 | jun. 2012
      • News nº 26 | fev/mar. 2012
      • News nº 25 | jan. 2012
    • 2010 – 2011
      • News nº 24 | nov/dez. 2011
      • News nº 23 | set/out. 2011
      • News nº 22 | jul/ago. 2011
      • News nº 21 | mai/jun. 2011
      • News nº 20 | mar/abr. 2011
      • News nº 19 | jan/fev. 2011
      • News nº 18 | dez. 2010
      • News nº 17 | out/nov. 2010
      • News nº 16 | ago/set. 2010
      • News nº 15 | jun/jul. 2010
      • News nº 14 | mai. 2010
      • News nº 13 | abr. 2010
      • News nº 12 | mar. 2010
      • News nº 11 | jan/fev. 2010
    • 2008 – 2009
      • News nº 10 | nov/dez. 2009
      • News nº 9 | out. 2009
      • News nº 8 | ago/set. 2009
      • News nº 7 | jul. 2009
      • News nº 6 | mai/jun. 2009
      • News nº 5 | abr. 2009
      • News nº 4 | mar. 2009
      • News nº 3 | jan/fev. 2009
      • News nº 2 | dez. 2008
      • News nº 1 | nov. 2008
  • Subscrever Newsletter
  • Contacto

14th Programme “Education through Science”

By etavares On 31 March, 2012 Research and Advanced Education | 2012 Comments Off on 14th Programme “Education through Science” No tags

The patient, the clinical situation and the relationship with health services –
an analysis of adherence to antiretroviral therapy by HIV-1 seropositive individuals

Project number 201100023

Tutor: Dr. Paulo Nicola
Students:  Maria Emília Pereira, Rita Martins, Violeta Nogueira
Co-tutor: Dr. Milene Fernandes 

Part of the ATAR-VIH project– Adherence to Antiretroviral Therapy by HIV seropositive individuals
(M Fernandes, L Caldeira, E Valadas, P Nicola, P Nogueira, AP Martins, V Maria)
2012

The patient, the clinical situation and the relationship with health services – an analysis of adherence to antiretroviral therapy by HIV seropositive individuals

• Introduction
Adherence to Antiretroviral Therapy (ART) is a major determinant for controlling HIV/AIDS (1).Given it is a multifactorial and complex behaviour, it is important to evaluate the role of individual characteristics as factors associated with adherence to ART.


Figure 1. Conceptual Model

• Objectives To identify determinants of adherence to ART among psychosocial factors, namely socio-demographic characteristics, satisfaction with social support and anxiety/depression.

• Methods We conducted a prospective observational cohort study on a systematic sample of adults infected with HIV-1 on ART who were being monitored at the Day Hospital for Infectious Diseases of Santa Maria Hospital and who had at least one medical appointment in the 3 months of recruitment.

 
The Adherence to Antiretroviral Therapy was evaluated based on the Adherence to Therapy Evaluation Questionnaire (Adult AIDS Clinical Trials Group), developed for self-assessment of adherence to therapy recently adhered to – last 4 days, weekend, and last 30 days – to minimize memory bias(2).

The Initial Questionnaire applied to participants also included the evaluation of:

A. Socio-Demographic Characteristics 
B. Satisfaction with Social Support (SSSS), a scale that varies between 15 and 75 points; the higher the total value of the scale, the greater the satisfaction with social support.
C. The Illness Perception Questionnaire (IPQ), a set of three distinct sections with 9 Likert type sub-scales of 5 points; the higher the value obtained, the greater the agreement with the causal attribution.
D. Depression, Anxiety, and Stress (DASS), a set of three scales, each ranging from 0 to 21 points; higher scores correspond to more negative states.

Assistant physicians were equally asked to complete a form providing clinical information about the consultation where the patient was invited to participate in the study. The association of adherence with other factors was evaluated using Student t- tests (continuous variables) and chi-square (categorical variables) assuming a=0,05.

• Results
Of a total of 306 individuals (Table 1) who had had a medical appointment during the recruitment period (May to July 2011), 203 eligible participants (participation rate: 66.3%) were included in the study. The most frequent causes for non-eligibility were the fact that patients came from other hospitals (12.1%), were infected with HIV -2 (4.2%), did not have the capacity to provide informed consent (3.3%), and were not on ART (3.0%). The refusal rate was 8.8%.

Table 1. Main socio-demographic and clinical characteristics of participants included in the study (n=203)

Of the 195 participants (Table 2) who answered all the questions in the questionnaire, 89 (45.6%) were classified as non-compliant and 172 (88.3%) reported never having missed taking antiretroviral medication in the past 7 days.

It was noted that non-compliance was associated with excessive consumption of alcohol in a short period of time <4 hours (“binge drinking”) (p=0.001) and higher scores in the depression(p=0.032) and anxiety (p=0.002).scales

Table.2 Factors associated with antiretroviral therapy

• Discussion

Demographic characteristics and transmission routes are consistent with the official national epidemiological data for 2010, with a percentage of male individuals being slightly lower in our study (75.4% vs. 81.1% in the official statistics).

Concerning factors related to individuals, it was found that socio-demographic variables did not influence adherence. This result may be partly explained by the smaller sample size in this study, which in turn was based on a population of predominantly European origin and with similar access to medication.

With regard to the patient’s clinical condition, we noted that the presence of non-infectious co-morbidities is associated with lower adherence, namely depression. On the other hand, the excessive consumption of alcohol in <4hours, anxiety, beliefs about HIV infection, and the capacity to take medication were identified as factors associated with non-compliance.

It must be stressed that the influence of the individual’s relationship with the various players in the health services, namely the doctor, could be subject to more thorough evaluation, which will be conducted in the six-month period of follow up of these participants.

Assessment of adherence using another objective method (i.e., registration of exemption of medication) and not only by self-report is also one of the things to verify when continuing this project.

• Conclusion 

The present study draws attention to the high prevalence of non-adherence and strengthens the need for clarification of the factors associated with it. It is important to develop adapted strategies such as, for example, psychological/psychiatric support to risk behaviours, such as the imbalanced intake of alcohol, depression and anxiety; development of training sessions/awareness raising sessions in order to change individuals’ misinterpretations regarding the disease and the ability to take medication, among others. It is the doctor’s responsibility to identify these situations for appropriate referral. The factors that have been identified are target areas for intervention and show the need for a multidisciplinary-follow up of individuals in order to better use ART.

• Future prospects 
In future, it would be interesting to conduct longer multi-centred studies indicating which are the most important factors in adherence, both in the short and medium term, and the importance of factors related to health care provided by distinct national hospitals.

• Acknowledgements 
To the participants and the team of the Day Hospital for Infectious Diseases of Santa Maria Hospital
To the research team of the ATAR-HIV study and colleagues conducting GAPIC projects associated with this study.
To the 14th Education through Science Programme.
The ATAR-HIV study was sponsored by the Merck, Sharp & Dohme Foundation, which had no implications on the data presented here. 

_____________(1)Lian YL, et al. AIDS-defining illnesses: A comparison between before and after commencement of highly active antiretroviral therapy (HAART). Curr HIV Res 2007;5(5):484-489.
(2)Chesney MA, et al. Self-reported adherence to antiretroviral medications among participants in HIC Clinical Trials: the AACTG Adherence Instruments. AIDS Care 2000;12(3): 255-266.
(3)Doutor Ricardo Jorge Institute. Department of Infectious Diseases, referral and epidemiological vigilance unit. Infection by HIV/AIDS, the situation in Portugal, 31st December 2010. Lisbon, February 2011. www.insa.pt, accessed in 2011/10/21

Share

Search

Index - News # 26 | fev/mar. 2012
 Editorial Note
 Northern Lisbon Hospital Centre Project wins Missão Sorriso
 Howard Hughes Medical Institute honours Five Portuguese Scientists
 Eighth Edition of L’Oreal Portugal Medals of Honour for Women in Science
 Plenary Assembly – “A new University of Lisbon”
 UCID – Lecturing Activity
 UCID – Research Activity
 UCID – Assistance Units
 UCID – Cooperation
 UCID – Projects Undertaken
 UCID – Publications
 CUDI – Experiences
 Year 6 Clinical Internship in Numers: From 2000-2001 to 2010-2011 (Part 2)
 Opening of the Calouste Gulbenkian Chair
 Searing-in Ceremony – Assembly of the Faculty
 Futurália 2012
 Dia do Candidato na FMUL
 Resultados do 15.º Programa “Educação pela Ciência”
 Scientific Publications
 14th Programme “Education through Science”
 Continuing Education Courses Faculty of Medicine UL – Not Leading to the Award of a Degree
 Professional Specialization Postgraduate Courses at the Faculty of Medicine
 Doctoral Degrees at the Faculty of Medicine of Lisbon
 Masters and PhD defenses in the Area of Infectious Diseases
 University Clinic of Infectious Diseases – Presentation
 IN MEMORIAM – Professor David Ferreira – Tribute
 Biographical File – Professor José Francisco David Ferreira
 Gabinete de Desporto – Universidade de Lisboa
 Science and Health Research
 A Day at the Faculty
 Vamos pôr Portugal a Dançar! (Portugal, Let’s Dance!) – From 21 to 29 April
 BIAL Award – 2012
 DIA SOLIDÁRIO – 24 de Abril de 2012
My Company

100 AnosPropriedade e Edição: Faculdade de Medicina da Universidade de Lisboa NIPC: 502662875  Periodicidade: Mensal  Diretor: Prof. Doutor Fausto J. Pinto Conselho Editorial: Prof. Doutor Fausto J. Pinto, Profª. Doutora Ana Sebastião, Prof. Doutor Mamede de Carvalho, Prof. Doutor António Vaz Carneiro, Prof. Doutor Miguel Castanho, Dr. Luís Pereira  Equipa Editorial:  Ana Raquel Moreira, Cristina Bastos, Isabel Varela, Joana Sousa, Maria de Lurdes Barata, Rui Gomes, Sónia Teixeira  Colaboração:  Gabinete de Relações Públicas, Internacionais e Comunicação  Versão Inglesa: AP|PORTUGAL- Language Services  Conceção: Metatexto, Lda. e-mail: news@medicina.ulisboa.pt  Sede do Editor e Sede da Redação: Avenida Prof. Egas Moniz, 1649-028 Lisboa Estatuto Editorial Anotado na ERC 

  • Increase Font
  • Decrease Font
  • Black & White
  • Inverse Colors
  • Highlight Links
  • Regular Font
  • Reset
Real Accessability